Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5604874 | 0.91 | ESR1 (0.46) | CA1CA2CA12CA4CA7 | |
| SCHEMBL28590662 | 0.87 | TSHR (0.49) | CA1CA2CA12CA4CA7 | |
| SCHEMBL15465790 | 0.83 | MEN1 (0.49) | CA1CA2CA12CA4CA7 | |
| SCHEMBL10690592 | 0.82 | CA12 (0.46) | CA1CA2CA12CA4CA7 | |
| SCHEMBL5965849 | 0.81 | AOC3 (0.45) | CA1CA2CA12CA4CA7 | |
| SCHEMBL30199730 | 0.81 | TDP1 (0.51) | MEN1KMT2APABPC1ALDH1A1LMNA | |
| SCHEMBL20607672 | 0.81 | KMT2A (0.42) | MEN1KMT2APABPC1ALDH1A1AGTR1 | |
| SCHEMBL12495567 | 0.81 | TDP1 (0.51) | MEN1KMT2APABPC1ALDH1A1LMNA | |
| SCHEMBL5470095 | 0.81 | CA1 (0.44) | CA1CA2CA12CA4CA7 | |
| SCHEMBL9763218 | 0.81 | CA1 (0.44) | CA1CA2CA12CA4CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2683714-B1 | II (PI)-CONJUGATED FLUOROIONOPHORES AND METHOD FOR DETERMINING AN ALKALI ION | UNIV POTSDAM (DE) | 2019-01-09 | — | — | EP | disclosed |
| WO-2012120141-A1 | Π (PI)-CONJUGATED FLUOROIONOPHORES AND METHOD FOR DETERMINING AN ALKALI ION | UNIVERSITÄT POTSDAM (DE) | 2012-09-13 | — | — | WO | disclosed |
| US-7858383-B2 | Chromoionophore and method of determining sodium ions | OPTI MEDICAL SYSTEMS (US) | 2010-12-28 | — | — | US | disclosed |
| WO-2007131054-A2 | CHROMOIONOPHORE AND METHOD OF DETERMINING SODIUM IONS | OPTI MEDICAL SYSTEMS (US) | 2007-11-15 | — | — | WO | disclosed |
| US-20070259444-A1 | ions are contacted with a compound having chromophoric and ionophoric moieties; the ionophoric moiety interacts with the ions present resulting in the chromophoric moiety changing its radiation absorption properties in the ultraviolet and visible regions of the spectrum; whole blood, plasma, serum, urine | OPTI MEDICAL SYSTEMS, INC. | 2007-11-08 | — | — | US | disclosed |
| US-20070078120-A1 | Novel piperidine derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| EP-1679069-A1 | NOVEL PIPERIDINE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2006-07-12 | — | — | EP | disclosed |
| EP-0393574-B1 | Hexitol derivatives | KYOWA HAKKO KOGYO KK (JP) | 1996-01-31 | — | — | EP | disclosed |
| US-5053408-A | Cardiovascular disorders | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-10-01 | — | — | US | disclosed |
| WO-1991010709-A1 | WATER-SOLUBLE DYES WHICH REACT WITH FIBRES, PROCESS FOR PRODUCING THEM AND THEIR USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-07-25 | — | — | WO | disclosed |
| EP-0393574-A2 | Hexitol derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0388864-A2 | Water-soluble, fibre-reactive dyes, method of their preparation and use | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-09-26 | — | — | EP | disclosed |
| EP-0104253-B1 | STABILIZER COMPOSITIONS FOR ANTIFOULING PAINTS | M & T CHEMICALS, INC. (US) | 1986-11-20 | — | — | EP | disclosed |
| US-4547532-A | Antifouling paint | M&T CHEMICALS INC. (US) | 1985-10-15 | — | — | US | disclosed |
| US-4477635-A | Polymeric triarylmethane dyes | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-10-16 | — | — | US | disclosed |
| US-4217102-A | Polyamides dyed with rubine disazo acid dyes and process therefore | Toms River Chemical Company (US) | 1980-08-12 | — | — | US | disclosed |
| US-4173565-A | Rubine disazo acid dyes for polyamides | TOMS RIVER CHEMICAL CORPORATION (US) | 1979-11-06 | — | — | US | disclosed |
| US-3997519-A | Method of producing quaternary pyridinium compounds | GAF CORPORATION (US) | 1976-12-14 | — | — | US | disclosed |
| US-3936556-A | Marking of articles | BAYER AKTIENGESELLSCHAFT (DT) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078120-A1 | Novel piperidine derivative | LDLR, PRMT5, MSR1 | CA1 4573/4885CA2 2999/4885CA12 4847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.